Skip to content

Nerve conduction studies changes in breast cancer patients undergoing chemotherapy and to study the protective effect of glutamine

The role of glutamine in prevention of chemotherapy- induced peripheral neuropathy in breast cancer patients - NIL

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/08/057147
Enrollment
50
Registered
2023-08-31
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C50- Malignant neoplasm of breast

Interventions

Intervention1: Glutamine powder 10 grams orally with water once daily(OD) for 4 days starting 24 hours after each chemotherapy cycle: Glutamine powder 10 g orally with water once daily for 4 days star

Sponsors

Jawaharlal Nehru Medical College Aligarh Muslim University Aligarh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Breast cancer diagnosed patients who are advised chemotherapy Patients willing to participate after informed consent Age 18 years and above Normal performance status (ECOG 2) Adequate renal and liver function No co- morbidities

Exclusion criteria

Exclusion criteria: Hypothyroidism or hyperthyroidism Diabetes mellitus Previously diagnosed neuropathy Pre existing autoimmune disease Anti tubercular OR Anti viral therapy Congestive heart failure, liver failure or renal failure Chronic anemia Chronic alcoholism, chronic smoking or drug abuse Previously chemotherapy received

Design outcomes

Primary

MeasureTime frame
Neuroprotective effect of glutamine on chemotherapy induced peripheral neuropathyTimepoint: Baseline, then serially after chemotherapy cycle and at chemotherapy completion

Secondary

MeasureTime frame
Improvement in quality of of life after preventive therapyTimepoint: Baseline, after chemotherapy cycle & full completion of chemotherapy

Countries

India

Contacts

Public ContactDr Naureen Rizvi

Department of Physiology, Jawaharlal Nehru medical college, AMU Aligarh

aslamm955@gmail.com9897536213

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026